News for Healthier Living

Moffitt Study Finds Vaccine May Improve Breast Cancer Treatment Outcomes

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen receptor-negative (HER2-positive, ER-negative) breast cancer and has shown encouraging results in a recent pilot study. Published in npj Breast Cancer, the study combined the HER2-targeting dendritic cell vaccines with standard chemotherapy, demonstrating both safety and positive response rates.

March 18, 2025


March 28 2025

March 27 2025

March 26 2025

March 25 2025

March 24 2025

March 23 2025

March 22 2025

March 21 2025

March 20 2025

March 19 2025

March 18 2025

March 17 2025

March 16 2025

March 15 2025